You are requesting information on: Amgen Phase III GAUSS-2 Trial of Evolocumab (AMG 145) Meets Co-Primary Endpoints Of LDL Cholesterol Reduction Bioprocess Online
Already a member of Bioprocess Online or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: